216 related articles for article (PubMed ID: 25120764)
1. Monocyte chemotactic protein-1 expression as a prognosic biomarker in patients with solid tumor: a meta analysis.
Wang H; Zhang Q; Kong H; Zeng Y; Hao M; Yu T; Peng J; Xu Z; Chen J; Shi H
Int J Clin Exp Pathol; 2014; 7(7):3876-86. PubMed ID: 25120764
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of octamer binding transcription factor 4 for patients with solid tumors: A meta-analysis.
Zhao X; Lu H; Sun Y; Liu L; Wang H
Medicine (Baltimore); 2020 Oct; 99(42):e22804. PubMed ID: 33080755
[TBL] [Abstract][Full Text] [Related]
3. Elevated peripheral absolute monocyte count related to clinicopathological features and poor prognosis in solid tumors: Systematic review, meta-analysis, and meta-regression.
Wen S; Chen N; Hu Y; Huang L; Peng J; Yang M; Shen X; Song Y; Xu L
Cancer Med; 2021 Mar; 10(5):1690-1714. PubMed ID: 33591628
[TBL] [Abstract][Full Text] [Related]
4. Tetraspanin CD151 as an emerging potential poor prognostic factor across solid tumors: a systematic review and meta-analysis.
Zeng P; Wang YH; Si M; Gu JH; Li P; Lu PH; Chen MB
Oncotarget; 2017 Jan; 8(3):5592-5602. PubMed ID: 27888619
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Role of TIGIT Expression in Patients with Solid Tumors: A Meta-Analysis.
Xiao K; Xiao K; Li K; Xue P; Zhu S
J Immunol Res; 2021; 2021():5440572. PubMed ID: 34888386
[TBL] [Abstract][Full Text] [Related]
6. Metallothioneins may be a potential prognostic biomarker for tumors: A Prisma-compliant meta-analysis.
Wang L; Xin F; Lin N; Wang Y; Liu X; Liu J
Medicine (Baltimore); 2018 Dec; 97(52):e13786. PubMed ID: 30593161
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Role of High Stathmin 1 Expression in Patients with Solid Tumors: Evidence from a Meta-Analysis.
Mao Q; Chen Z; Wang K; Xu R; Lu H; He X
Cell Physiol Biochem; 2018; 50(1):66-78. PubMed ID: 30278466
[TBL] [Abstract][Full Text] [Related]
8. Association between Alpha B-crystallin expression and prognosis in patients with solid tumors: A protocol for systematic review and meta-analysis.
Yang M; Li Y; Tian F
Medicine (Baltimore); 2021 Feb; 100(7):e24831. PubMed ID: 33607849
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of lymphocyte-to-monocyte ratio in patients with solid tumors: A systematic review and meta-analysis.
Nishijima TF; Muss HB; Shachar SS; Tamura K; Takamatsu Y
Cancer Treat Rev; 2015 Dec; 41(10):971-8. PubMed ID: 26481060
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Significance of Tumor-Infiltrating Natural Killer Cells in Solid Tumors: A Systematic Review and Meta-Analysis.
Zhang S; Liu W; Hu B; Wang P; Lv X; Chen S; Shao Z
Front Immunol; 2020; 11():1242. PubMed ID: 32714321
[No Abstract] [Full Text] [Related]
11. Prognostic value of long non-coding RNA FOXD2-AS1 expression in patients with solid tumors.
Zhou L; Li Z; Shao X; Yang B; Feng J; Xu L; Teng Y
Pathol Res Pract; 2019 Sep; 215(9):152449. PubMed ID: 31378453
[TBL] [Abstract][Full Text] [Related]
12. The prognostic value of the C-reactive protein to albumin ratio in cancer: An updated meta-analysis.
Cui X; Jia Z; Chen D; Xu C; Yang P
Medicine (Baltimore); 2020 Apr; 99(14):e19165. PubMed ID: 32243358
[TBL] [Abstract][Full Text] [Related]
13. High expression of HOXB7 is an unfavorable prognostic factor for solid malignancies: A meta-analysis.
Zhou T; Feng Z; Yang F; Zhu W; Cao J; Hou X; Zhao Y; Chen D
Medicine (Baltimore); 2022 Jan; 101(3):e28564. PubMed ID: 35060516
[TBL] [Abstract][Full Text] [Related]
14. Prognostic and clinicopathological significance of MicroRNA-153 in human cancers: A meta-analysis.
Huang M; Li C; Kong F; Wu Y; Yuan Q; Hu L
Medicine (Baltimore); 2020 Nov; 99(46):e22833. PubMed ID: 33181653
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Significance of the Metabolic Marker Hexokinase-2 in Various Solid Tumors: A Meta-Analysis.
Liu Y; Wu K; Shi L; Xiang F; Tao K; Wang G
PLoS One; 2016; 11(11):e0166230. PubMed ID: 27824926
[TBL] [Abstract][Full Text] [Related]
16. Golgi phosphoprotein3 overexpression is associated with poor survival in patients with solid tumors: a meta-analysis.
Jiang Y; Su Y; Zhao Y; Pan C; Chen L
Int J Clin Exp Pathol; 2015; 8(9):10615-24. PubMed ID: 26617771
[TBL] [Abstract][Full Text] [Related]
17. Association Between Pretreatment Serum Apolipoprotein A1 and Prognosis of Solid Tumors in Chinese Population: A Systematic Review and Meta-Analysis.
Wu J; Zhang C; Zhang G; Wang Y; Zhang Z; Su W; Lyu J
Cell Physiol Biochem; 2018; 51(2):575-588. PubMed ID: 30466099
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of FOXM1 in solid tumors: a systematic review and meta-analysis.
Li L; Wu D; Yu Q; Li L; Wu P
Oncotarget; 2017 May; 8(19):32298-32308. PubMed ID: 28427178
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Value of HHLA2 in Patients with Solid Tumors: A Meta-Analysis.
Kula A; Dawidowicz M; Mielcarska S; Świętochowska E; Waniczek D
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731979
[TBL] [Abstract][Full Text] [Related]
20. Metastasis-associated protein 1 as a new prognostic marker for solid tumors: a meta-analysis of cohort studies.
Luo H; Li H; Yao N; Hu L; He T
Tumour Biol; 2014 Jun; 35(6):5823-32. PubMed ID: 24599674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]